Cycle: 12 weeks on, 4 weeks off
The LEADER trial followed patients for 3-5 years and found no effect on calcitonin levels and no new thyroid cancers
"These groundbreaking medications are poised to revolutionize cardiovascular care and could dramatically enhance cardiovascular health." In two new substudies of the SELECT Trial, which included people who had overweight or obesity according to their BMI and had established cardiovascular disease but not diabetes, researchers looked at whether once weekly semaglutide (2.4 mg) reduced rates of all-cause death, cardiovascular death and noncardiovascular death, including death from COVID-19, and whether sex impacts the efficacy and safety of the drug
Ipamorelin Peptide Potential on Bone Cell Anabolism In laboratory models exposed to catabolic agents, research by Andersen et al
Seeking out nutrient-dense foods when you're on a GLP-1 diet isn't easy, especially if you've got a hectic lifestyle
The National Weight Control Registry, which tracks individuals who have maintained significant weight loss (30 pounds for 1 year), identifies common characteristics among successful maintainers